Delivery Order SPE2DB24D2215-SPE2DB25FGTLD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mresvia 50 mcg/0.5 mL syringes with a ceiling value of $14,920.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 20, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action under a larger federal contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mresvia 50 mcg/0.5 mL syringes with a ceiling value of $29,841.60. The delivery order is structured as a firm fixed price contract with an ultimate completion date of October 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a competitive award with no set-aside designation, reflecting the contractor's proven capability to...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,740.75 to AmerisourceBergen Drug Corp on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,045.24 to AmerisourceBergen Drug Corp on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled...
- The Defense Logistics Agency Medical Supply Chain awarded a $59,772.68 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $40,641.02 to AmerisourceBergen Drug Corp on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $265,980 to AmerisourceBergen Drug Corp on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order, issued under contract number 4569356757, represents a competitively awarded, non-set-aside procurement with no preferential consideration applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,140.36 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a competitive, non-set-aside procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $119,950.23 to AmerisourceBergen Drug Corp on September 18, 2025, with completion targeted for the same date. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical support vehicle extending through December 2026. The delivery order will be...
- The Defense Logistics Agency Medical Supply Chain awarded a $50,396.40 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, with completion expected by September 15, 2025. This firm fixed-price contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively procured with no set-aside designation. AmerisourceBergen,...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB25FGTLDDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,492.08 delivery order to AmerisourceBergen Drug Corp for Mresvia 50 micrograms/0.5 milliliter syringes on September 26, 2025, with an ultimate completion date of October 20, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, particularly for military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages its comprehensive IDC with the DLA to supply a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's consistent track record of winning competitively awarded contracts demonstrates its capability to meet federal procurement requirements for specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/26/25 |